Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Why DarioHealth Corp. (NASDAQ: DRIO) Is ‘One to Watch’

DarioHealth (NASDAQ: DRIO) is a pioneer in the global digital therapeutics market focused on delivering evidence-based interventions to people with chronic conditions. A recent article discussing DarioHealth reads, “Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.”

To view the full article, visit http://ibn.fm/oniQE

About DarioHealth Corp.

DarioHealth is a leading, global, digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the company empowers individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. The company’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario offers one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, visit  www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DarioHealth are available in the company’s newsroom at http://ibn.fm/DRIO  

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in DarioHealth Corp. DRIO | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces New Board Appointments

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the appointment of three new members to the company’s board of directors, effective immediately. According to the update, joining the board as independent directors are: Dr. Nancy Chung-Welch, Ph.D., Charles L. Nuzum, CPA and Greg St. Clair. “These appointments signify our absolute commitment to aligning our Board’s expertise with the company’s strategic vision of developing and commercializing an offering that will enable us to support the improvement in healthcare outcomes for oncology patients and increase value to our shareholders,” Dr. Carl Schwartz, Predictive Oncology CEO, said in the news release. “Each of these members brings a wealth of knowledge, experience and thought leadership that will be highly valuable as we execute our plans to develop and market AI-based predictive models that leverage our unique tumor bank.”

To view the full press release, visit http://ibn.fm/mNwqL

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Poised for Opportunity in the Business of Big Data

SRAX (NASDAQ: SRAX) is positioned for opportunity in the business of big data, leveraging technology that unlocks information to reveal brands’ core consumers and their characteristics across several marketing channels. SRAX’s BIGtoken platform integrates all aspects of the advertising experience into a one-stop shop and allows monetization of specialized data sets across several verticals. A recent article discussing this quotes SRAX CEO and founder Christopher Miglino, who says, “’Our primary focus is figuring out ways to monetize different data sets. We had a business a few years ago where we aggregated data on doctors in the country, and then we sold that data,’ said Miglinio, referring to SRAX’s healthcare vertical, SRAX MD, that sold for a $43.5 million consideration while allowing SRAX to retain a 31% ownership.”

To view the full article, visit http://ibn.fm/x7Pqj

About SRAX

SRAX is a digital-marketing and consumer data-management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends, and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in SRAX, Inc. SRAX | Leave a comment

Trxade Group, Inc. (NASDAQ: MEDS) Telehealth App Incorporates New Educational Resources for Patients

  • Pharmaceutical and health care services company Trxade Group has added new tools to its Bonum Health telemedicine platform that will help patients better inform themselves about their medical needs and their provider’s prescription recommendations
  • Trxade Group operates a B2B pharmaceutical network that supports independent, neighborhood-based healthcare businesses with up-to-the-minute information on drug pricing
  • The company also assists patients on a B2C basis through its subsidiaries that include Bonum Health’s telemedicine platform and Delivmeds’ pharmaceutical delivery service
  • Trxade Group’s development of remote-access medical care during the past two years has proven timely in the face of restrictions on gatherings imposed during the novel coronavirus pandemic
  • The company has been increasing its profile among investors with uplisting to the Nasdaq exchange and entry to the annual Russell’s Microcap Index

Growing health services provider Trxade Group (NASDAQ: MEDS) recently announced the expansion of its patient empowerment telehealth platform Bonum Health, which has added access to educational resources that can help better understand and direct their care management.

Trxade Group’s wholly owned mobile telehealth application will now link to the Merck Manual, a standard reference guide for physicians since 1899, according to the announcement. The company’s intent in further developing the Bonum Health app is to “encourage, enable, and empower patients” with information pertinent to their medical needs and provider’s drug recommendations.

Trxade Group has been undergoing significant portfolio development during recent months. The company’s mission is to help sustain independent, locally owned community pharmacies, and two years ago it boosted its own capacity to reach consumers directly when it acquired accredited Internet pharmaceutical Community Specialty Pharmacy, LLC (http://ibn.fm/Y0xaU) and launched its consumer-based medication delivery app Delivmeds.com.

Trxade Group has since added its Bonum Health Hub telehealth service as a means for patients and providers to consult using mobile smart tech without a need for in-office visits. The secure, privacy-enabled technology has proven particularly timely during a year when a novel coronavirus reached pandemic-level global transmission and spurred health and government leaders to enact varied restrictions against group gatherings (http://ibn.fm/lCYCQ).  

Trxade Group has this year seen its operation uplisted to the Nasdaq exchange as it has gathered funding, and last month it gained inclusion on this year’s Russell’s Microcap Index.

“This marks an exciting capital markets milestone in the growth and trajectory of our company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community,” Trxade Chairman and CEO Suren Ajjarapu stated in a news release at the time (http://ibn.fm/7qjoH).

Trxade Group’s eBay-type B2B business model significantly lowers prescription drug costs, in part due to its emphasis on transparency. At the same time, the company’s revenues grew 94 percent during 2019 as a result of fee income for medications listed on the company’s web-based market platform (http://ibn.fm/U20h6) and 11,400 independent pharmacies became new subscribers to the company’s platform for analyzing drug pricing on an up-to-the-minute basis.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS  

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRTC) Announces BolaWrap(R) Training for Seven New Agencies

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced that it is scheduled to train seven new agencies on the BolaWrap in Maryland on Tuesday, July 14, 2020. According to the update, Landover Hills Police Department will host the “Train the Trainer” session for 16 trainers from seven different local agencies. “We are very encouraged with how quickly agencies are opting to receive training,” Rick Guilbault, VP of Training at Wrap Technologies, said in the news release. “Agencies that receive in-person demonstrations or attend online webinar demonstrations of the BolaWrap are quickly moving to schedule ‘Train the Trainer’ sessions to certify their trainers on the BolaWrap, which enables them to train the rest of their agencies. To date, Wrap Training Academy has 50 BolaWrap Master Instructors who have trained over 790 trainers from police agencies across the world.”

To view the full press release, visit http://ibn.fm/gyw03

About Wrap Technologies (NASDAQ: WRTC)

Wrap Technologies is an innovator of modern policing solutions. The Company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the Company’s Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. For information on the Company please visit www.WrapTechnologies.com. Examples of recent media coverage are available as links under the “Media” tab of the website.

NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://ibn.fm/WRTC

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Wrap Technologies Inc. WRTC | Leave a comment

MissionIRNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Provides Update on Pending Mullen Technologies Merger; Mullen Enters LOI to Acquire EV Manufacturing Plant

Net Element (NASDAQ: NETE), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce and mobile devices, today provided an update on the pending merger with Mullen Technologies, Inc., a Southern California-based electric vehicle (“EV”) company. “We are working earnestly on due diligence and other matters in the hope of bringing this merger to fruition for the benefit of our shareholders,” Oleg Firer, executive chairman and CEO of Net Element, said in the news release. “The EV industry continues showing robust growth and if consummated, we believe the merger can increase shareholder value.”

In addition, Mullen today announced its entry into a letter of intent (“LOI”) with Axiom Financial for $135 million in funding to acquire and build out an electric vehicle manufacturing plant. “As we move forward with our acquisition of Net Element, the immediate need to develop a facility to manufacture and assemble our vehicles becomes a high priority,” Mullen CEO David Michery stated in the news release. “Modifying an existing, functional plant to create our vehicles will immediately catapult Mullen into very rare territory: an electric car manufacturer producing vehicles and distributing them throughout our internal network of dealers.”

To view the full press releases, visit http://ibn.fm/0d5Nt and http://ibn.fm/ovTQX

About Net Element

Net Element, Inc. operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., the Company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, its cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500(TM). In 2017, it was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Net Element Inc. NETE | Leave a comment

SRAX Inc. (NASDAQ: SRAX) Investor Data Analytics Platform Setting Industry Standards

  • SRAX’s Sequire platform has grown to 75 publicly traded companies comprising 500,000+ active investors
  • Sequire’s sales exceeded $2.5 million in Q2 2020 with additional $3 million expected to close in Q3
  • Platform expansion set to follow definitive securities purchase agreement worth $13 million

With the importance of big data on the rise, it should come as no surprise that the finance industry is leveraging the use of data analytics to deliver increased transparency and improve communications with stakeholders on every level. SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, is leveraging this trend through Sequire, its innovative investor intelligence platform. Through the use of proprietary technology, Sequire unlocks big data analytics in powerful new ways that connect public companies with traders and long-term investors for communication and marketing campaigns.

Interactions between public companies, shareholders and future prospects are becoming increasingly complex, requiring innovative new strategies and creative solutions that only big data can provide. Sequire facilitates these communications through an online platform that allows public companies to monitor the activities of current investors, activate campaigns to engage existing shareholders and create marketing campaigns to attract new investment to the company.

Sequire’s success – despite the effect of COVID-19 lockdowns – has been significant so far in 2020, growing to 75 publicly-traded companies comprising 500,000+ active investors and traders with sales exceeding $2.5 million in Q2 2020 (http://ibn.fm/Z6LGF). Expansion of the platform is imminent following recent news that the Company has entered into a definitive securities purchase agreement led by existing institutional investors for the purchase and sale of $13 million senior secured convertible debentures to fund a rapid expansion of the platform (http://ibn.fm/4zZla).

“On Thursday, we announced a capital raise of $13 million, which we will use in part to fund the rapid expansion of Sequire,” said SRAX CEO and founder Christopher Miglino (http://ibn.fm/4d3g5). “Our clients have seen notable results from the platform and its related services. We’ve also seen a significant increase in the number of clients on the platform with Q2 sales hitting over $2.5 million and an additional $3 million in the pipeline, with a very high probability of closing in Q3.”

Along with Sequire, SRAX delivers a suite of specialized tools for other industries, delivering a digital competitive advantage for brands in the CPG, luxury goods and lifestyle verticals by integrating all aspects of the advertising experience into one platform. At a time when consumers are becoming increasingly aware of the value of their data, SRAX is more than several steps ahead with the company’s BIGtoken platform, comprising over 16 million users and providing them with compensation for their data while simultaneously creating reliable data sets that can be accessed by marketers for a fee.

New, innovative and creative uses of big data are increasingly being used to meet the demands of businesses looking to survive the current economic period. SRAX’s services meet this demand by giving clients the ability to target and access specific niche groups across 25,000 unique points of segmentation, providing a much-needed strategic edge to businesses of all types across almost every industry.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. to Host Investor Due Diligence ‘Last Chance’ Webinar on July 18

Knightscope, a company that designs and builds Autonomous Security Robots (“ASRs”) that provide 24/7/365 security in a variety of different locations, will be hosting a webinar on Saturday July 18, 2020 at 1 PM ET (10 AM PT). This is the last opportunity to ask Knightscope Chairman and CEO William Santana Li any due diligence questions before the current Reg A+ Investment Offering comes to an end on Monday July 20, 2020 at the current share price of $8.00. Questions will be answered live from Knightscope Headquarters in Silicon Valley.

To register for the webinar, visit http://ibn.fm/4UZ8f

About Knightscope

Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots that deter, detect and report. The company’s long-term ambition is to make the United States of America the safest country in the world. Visit www.securityrobot.com for more information.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Knightscope, Inc., MissionIRNewsBreaks | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Releases Q1 2020 Financial, Business Report; Revenues Up, Margins Stay Strong

  • POAI improved liquidity position, streamlined capital structure with conversion of $2.1 million convertible note
  • Business highlights include continued initial study to sequence ovarian tumors, validate “reach-back”
  • Company closed transaction resulting in gross cash proceeds of approximately $2.2 million

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced Q1 2020 financial results and business highlights (http://ibn.fm/mFwpq) as well as receipt of cash proceeds of $2.2 million from exercise of warrants (http://ibn.fm/2n6x5).

“[POAI] improved our liquidity position and streamlined our capital structure with the conversion of a $2.1 million convertible note, previously held by me, to newly issued equity,” said POAI CEO Dr. Carl Schwartz. “This action demonstrates my confidence in the commercial viability of our work, and when combined with the additional capital we raised through an equity offering, provides us with the cash runway to fund key clinical, regulatory and operational milestones for the next several quarters. In addition, we have significantly reduced the corporate structure of our Skyline Medical business to enable it to operate independently as we consider strategic alternatives for this business.”

According to Predictive Oncology’s report, for the quarter ended March 31, 2020, company revenues increased to $295,943 compared with $255,241 for the first quarter of 2019. Gross margins remained strong at 69% for the same period, compared with 71% in the 2019 period. Other Q1 highlights included the following:

  • Continued initial study to sequence ovarian tumors and validate “reach-back” process; study is on schedule to be completed Q3 2020
  • Signed LOI to acquire Quantitative Medicine, a biomedical analytics and computational biology company; closed early July Q3 2020
  • Signed a term sheet to acquire both BioDtech and Soluble Therapeutics and its HSC(TM) Technology; closed in Q2 2020

In addition, POAI announced the closing of a previously announced transaction resulting in gross cash proceeds of approximately $2.2 million paid to the company, prior to deducting placement agent fees and offering expenses, through the exercise of certain existing warrants by several holders to purchase an aggregate of up to 1,396,826 shares of common stock at an exercise price of $1.575 per share. The shares of common stock issued upon exercise of the existing warrants are registered for resale pursuant to a registration statement on Form S-1.

In consideration for the immediate exercise of the existing warrants for cash, the exercising holders received new unregistered warrants to purchase up to an aggregate of 1,396,826 shares of common stock at an exercise price of $1.80 per share with an exercise period of five and one-half years from the issuing date. Predictive Oncology plans to use these funds for working capital and general corporate purposes.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through the company’s Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a road map to help individualize therapy. In addition, the company is utilizing artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Jerrick Media Holdings Inc. (JMDA) Recaps First Annual Virtual Shareholder Meeting

Jerrick Media Holdings (OTCQB: JMDA), a technology company and the parent company of Vocal, today announced successful conclusion of what was its first annual shareholder meeting. Among many highlights, the virtual meeting centered around Jerrick’s vision for now and in the future, focusing on the Vocal platform, which is at the heart of the company’s growth strategy. “I was very impressed with the shareholder meeting. Integrating animations, tastefully explaining the relevancy of the company’s vision in today’s environment, and visually explaining Jerrick/Creatd’s improved advertising model were all highlights for me,” InvestorBrandNetwork’s Communications Director, Jonathan Keim, said of his attendance of the virtual meeting. “It was also well appreciated that a highly visual transcript was provided soon after the live call. We’re excited to see everything that transpires over the remainder of this year and beyond.”

To view the full article, visit http://ibn.fm/19dMZ

About Jerrick

Jerrick Media Holdings, Inc. is the parent company and creator of the Vocal platform. The Company creates technology-based solutions to solve problems for the creative community. Through Vocal, Jerrick identifies and leverages opportunities within the digital platform and content monetization space. Since launching in 2016, Vocal has become home to over 600,000 content creators and brands of all shapes and sizes, attracting audiences across its network of wholly owned and operated communities. For more information, visit the company’s website at https://jerrick.media.

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://ibn.fm/JMDA

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Jerrick Media Holdings Inc. JMDA, MissionIRNewsBreaks | Leave a comment